IVC Acquisition Ltd - Period Ending 2020-09-30

IVC Acquisition Ltd - Period Ending 2020-09-30


IVC Acquisition Ltd 10505083 false 2019-10-01 2020-09-30 2020-09-30 The principal activity of the company is that of an intermediate parent company. The company is part of the IVC Evidensia group which provides veterinary services and products to customers and their pets in a number of countries across Europe. Digita Accounts Production Advanced 6.29.9459.0 Software true true true true false false false false false false false false false false 10505083 2019-10-01 2020-09-30 10505083 2020-09-30 10505083 bus:Director1 2020-09-30 10505083 bus:Director4 2020-09-30 10505083 bus:Director8 2020-09-30 10505083 bus:OrdinaryShareClass1 2020-09-30 10505083 bus:OrdinaryShareClass2 2020-09-30 10505083 bus:Consolidated 2020-09-30 10505083 core:FurtherSpecificReserve1ComponentTotalEquity 2020-09-30 10505083 core:OtherReservesSubtotal 2020-09-30 10505083 core:RetainedEarningsAccumulatedLosses 2020-09-30 10505083 core:ShareCapital 2020-09-30 10505083 core:SharePremium 2020-09-30 10505083 core:CurrentFinancialInstruments 2020-09-30 10505083 core:CurrentFinancialInstruments core:WithinOneYear 2020-09-30 10505083 core:Non-currentFinancialInstruments 2020-09-30 10505083 core:Non-currentFinancialInstruments core:AfterOneYear 2020-09-30 10505083 core:CostValuation 2020-09-30 10505083 core:OtherPropertyPlantEquipment 2020-09-30 10505083 bus:FRS102 2019-10-01 2020-09-30 10505083 bus:Audited 2019-10-01 2020-09-30 10505083 bus:FullAccounts 2019-10-01 2020-09-30 10505083 bus:RegisteredOffice 2019-10-01 2020-09-30 10505083 bus:Director1 2019-10-01 2020-09-30 10505083 bus:Director2 2019-10-01 2020-09-30 10505083 bus:Director3 2019-10-01 2020-09-30 10505083 bus:Director4 2019-10-01 2020-09-30 10505083 bus:Director5 2019-10-01 2020-09-30 10505083 bus:Director8 2019-10-01 2020-09-30 10505083 bus:HighestPaidDirector 2019-10-01 2020-09-30 10505083 bus:OrdinaryShareClass1 2019-10-01 2020-09-30 10505083 bus:OrdinaryShareClass2 2019-10-01 2020-09-30 10505083 bus:Consolidated 2019-10-01 2020-09-30 10505083 bus:PrivateLimitedCompanyLtd 2019-10-01 2020-09-30 10505083 bus:Agent1 2019-10-01 2020-09-30 10505083 core:FurtherSpecificReserve1ComponentTotalEquity 2019-10-01 2020-09-30 10505083 core:RetainedEarningsAccumulatedLosses 2019-10-01 2020-09-30 10505083 core:ShareCapital 2019-10-01 2020-09-30 10505083 core:SharePremium 2019-10-01 2020-09-30 10505083 countries:UnitedKingdom 2019-10-01 2020-09-30 10505083 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2019-10-01 2020-09-30 10505083 core:OtherPropertyPlantEquipment 2019-10-01 2020-09-30 10505083 core:Subsidiary1 2019-10-01 2020-09-30 10505083 core:Subsidiary1 countries:AllCountries 2019-10-01 2020-09-30 10505083 core:Subsidiary2 2019-10-01 2020-09-30 10505083 core:Subsidiary2 countries:AllCountries 2019-10-01 2020-09-30 10505083 core:Subsidiary3 2019-10-01 2020-09-30 10505083 core:Subsidiary3 countries:AllCountries 2019-10-01 2020-09-30 10505083 core:Subsidiary4 2019-10-01 2020-09-30 10505083 core:Subsidiary4 countries:AllCountries 2019-10-01 2020-09-30 10505083 core:Subsidiary5 2019-10-01 2020-09-30 10505083 core:Subsidiary5 countries:AllCountries 2019-10-01 2020-09-30 10505083 core:Subsidiary6 2019-10-01 2020-09-30 10505083 core:Subsidiary6 countries:AllCountries 2019-10-01 2020-09-30 10505083 core:Subsidiary7 2019-10-01 2020-09-30 10505083 core:Subsidiary7 countries:AllCountries 2019-10-01 2020-09-30 10505083 core:Subsidiary8 2019-10-01 2020-09-30 10505083 core:Subsidiary8 countries:AllCountries 2019-10-01 2020-09-30 10505083 core:Subsidiary9 2019-10-01 2020-09-30 10505083 core:Subsidiary9 countries:AllCountries 2019-10-01 2020-09-30 10505083 core:UKTax 2019-10-01 2020-09-30 10505083 1 2019-10-01 2020-09-30 10505083 2 2019-10-01 2020-09-30 10505083 4 2019-10-01 2020-09-30 10505083 countries:AllCountries 2019-10-01 2020-09-30 10505083 2019-09-30 10505083 core:FurtherSpecificReserve1ComponentTotalEquity 2019-09-30 10505083 core:RetainedEarningsAccumulatedLosses 2019-09-30 10505083 core:ShareCapital 2019-09-30 10505083 core:SharePremium 2019-09-30 10505083 core:AdditionsToInvestments 2019-09-30 10505083 core:OtherPropertyPlantEquipment 2019-09-30 10505083 2018-10-01 2019-09-30 10505083 2019-09-30 10505083 bus:OrdinaryShareClass1 2019-09-30 10505083 bus:OrdinaryShareClass2 2019-09-30 10505083 core:FurtherSpecificReserve1ComponentTotalEquity core:RestatedAmount 2019-09-30 10505083 core:OtherReservesSubtotal core:RestatedAmount 2019-09-30 10505083 core:RetainedEarningsAccumulatedLosses 2019-09-30 10505083 core:ShareCapital 2019-09-30 10505083 core:SharePremium core:RestatedAmount 2019-09-30 10505083 core:CurrentFinancialInstruments core:WithinOneYear core:RestatedAmount 2019-09-30 10505083 core:CurrentFinancialInstruments core:RestatedAmount 2019-09-30 10505083 core:Non-currentFinancialInstruments 2019-09-30 10505083 core:Non-currentFinancialInstruments core:AfterOneYear 2019-09-30 10505083 core:Non-currentFinancialInstruments core:AfterOneYear core:RestatedAmount 2019-09-30 10505083 core:CostValuation 2019-09-30 10505083 core:OtherPropertyPlantEquipment 2019-09-30 10505083 core:RestatedAmount 2019-09-30 10505083 bus:HighestPaidDirector 2018-10-01 2019-09-30 10505083 core:FurtherSpecificReserve1ComponentTotalEquity 2018-10-01 2019-09-30 10505083 core:FurtherSpecificReserve1ComponentTotalEquity core:RestatedAmount 2018-10-01 2019-09-30 10505083 core:RetainedEarningsAccumulatedLosses 2018-10-01 2019-09-30 10505083 core:ShareCapital 2018-10-01 2019-09-30 10505083 core:SharePremium 2018-10-01 2019-09-30 10505083 core:SharePremium core:RestatedAmount 2018-10-01 2019-09-30 10505083 countries:UnitedKingdom 2018-10-01 2019-09-30 10505083 core:Subsidiary1 2018-10-01 2019-09-30 10505083 core:Subsidiary2 2018-10-01 2019-09-30 10505083 core:Subsidiary3 2018-10-01 2019-09-30 10505083 core:Subsidiary4 2018-10-01 2019-09-30 10505083 core:Subsidiary5 2018-10-01 2019-09-30 10505083 core:Subsidiary6 2018-10-01 2019-09-30 10505083 core:Subsidiary7 2018-10-01 2019-09-30 10505083 core:Subsidiary8 2018-10-01 2019-09-30 10505083 core:Subsidiary9 2018-10-01 2019-09-30 10505083 core:UKTax 2018-10-01 2019-09-30 10505083 2018-09-30 10505083 core:FurtherSpecificReserve1ComponentTotalEquity 2018-09-30 10505083 core:RetainedEarningsAccumulatedLosses 2018-09-30 10505083 core:ShareCapital 2018-09-30 10505083 core:SharePremium 2018-09-30 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 10505083

IVC Acquisition Ltd

Annual Report and Financial Statements

for the Year Ended 30 September 2020

 

IVC Acquisition Ltd

Contents

Company Information

1

Strategic Report

2 to 7

Directors' Report

8 to 9

Statement of Directors' Responsibilities

10

Independent Auditor's Report

11 to 13

Profit and Loss Account

14

Balance Sheet

15

Statement of Changes in Equity

16

Notes to the Financial Statements

17 to 45

 

IVC Acquisition Ltd

Company Information

Directors

S M Clarke

P G Franzen

M A Gillings

P M Kenyon

A Reza

Registered office

The Chocolate Factory
Keynsham
Bristol
BS31 2AU

Bankers

HSBC Bank PLC
Second Floor
HSBC Building
Mitchell Way
Southampton
SO18 2XU

Auditor

Deloitte LLP
Bristol
United Kingdom

 

IVC Acquisition Ltd

Strategic Report for the Year Ended 30 September 2020

The directors present their Strategic Report for the year ended 30 September 2020.

Principal activity

The principal activity of the company is that of an intermediate parent company. The company is part of the IVC Evidensia group which provides veterinary services and products to customers and their pets in a number of countries across Europe.

Fair review of the business

The results for the year, which are set out in the profit and loss account, show an operating loss of £5M (2019 - £7M). The loss before taxation for the year ended 30 September 2020 was £78M (2019 - £96M). At 30 September 2020, the company had net assets of £281M (2019 - £354M).

The directors are pleased with the results for the year, particularly given the impact the Covid-19 pandemic had on the third quarter of the year. Despite the impact of the Covid-19 pandemic, the results for the year are in line with management’s expectations at the start of the year reflecting how well the business recovered from the impact and how resilient it is to economic downturns.
 

Principal risks and uncertainties
IVC Acquisition Limited is an investment holding company of IVC Evidensia. It indirectly owns 1,536 sites (2019 - 1,345) of vet practices and crematoria across the United Kingdom and Europe through a number of subsidiaries. During the year, the Group continued its expansion plans and entered new markets such as Belgium.

The management of the business and the execution of the company’s strategy are subject to a number of risks. The key business risks and uncertainties affecting the company are considered to relate to competition from both national and local providers of veterinary services and the general state of the veterinary industry. The principal risks and uncertainties for IVC Evidensia can be found in the IVC Acquisition Pikco Limited accounts on page 3. There are no risks specifically relating to this company.

Key performance indicators
There are no key performance indicators specifically monitored for this company. For performance indicators of the IVC Evidensia group please see IVC Acquisition Pikco Limited accounts.

 

IVC Acquisition Ltd

Strategic Report for the Year Ended 30 September 2020 (continued)

Going concern
In accordance with the Financial Reporting Council's 'Going Concern and Liquidity Risk: Guidance for Directors of UK Companies 2016' the directors of all companies are required to provide disclosures regarding the adoption of the going concern basis of accounting.

The financial statements include details of the financial position of the Company, its liquidity position and borrowing.

The Company is part of the IVC Evidensia Group (“the Group”) in which a detailed going concern assessment has been made. The Group meets its day-to-day working capital requirements through operating cash flows and its acquisition requirements through senior debt facilities. The Group’s forecasts and projections, covering a period of at least 12 months from the approval of these financial statements, show that the Group should be able to operate within the level of its current debt facilities. After taking account of reasonably possible changes in trading performance, no material uncertainty exists regarding covenant compliance on the Group’s existing facilities.

As part of the going concern assessment, the Group modelled various scenarios including the impact of reasonable possible changes related to the Covid-19 pandemic. These reflected the learnings and changes implemented as a result of the pandemic thus far and Government initiatives or grants were assumed to be unavailable. It was assumed that the impact will be less severe than the first wave, as, since that point in time:

• The industry regulators have accepted that the veterinary sector is an essential service so restrictions on services would be minimal.
• Clinics would remain open having the personal, protective equipment they need and having tried and tested alternative working procedures in place.
• Following the first national lock down that ended in July 2020, the Group has seen no significant impact on revenue in areas which have been subject to subsequent local lock downs, indicating that the actions taken by the Group, and the reaction of customers, has been such that trading at or above pre-lock down levels will continue despite further lock downs.

The sensitivities applied were as follows:

• impact of Brexit in the form of delays in receiving inventory;
• increase in bank interest rates by 1%;
• a devaluation of GBP vs Swedish Krona/Euro by 10%; and
• a reduction of revenue corresponding to 25% of FY20 revenue with a reduction in Gross profit at the same margin as FY20 and assuming no additional Covid-19 initiatives are available.

The sensitivity analyses showed that the Group and therefore the Company would still have sufficient cash flows to allow it to service the Company and its’ subsidiaries’ debt and settle trading liabilities, and comply with covenant requirements under its banking facilities for a period of at least 12 months from the date of signing of the financial statements.

The directors therefore have a reasonable expectation that the Group and therefore the Company has adequate resources to continue in operational existence for the foreseeable future. Accordingly, they continue to adopt the going concern basis of accounting in preparing the annual financial statements.

 

IVC Acquisition Ltd

Strategic Report for the Year Ended 30 September 2020 (continued)

Section172 (1) statement

The directors of the Company are required to act in accordance with the duties detailed in section 172 of the Companies Act 2006, which are summarised as follows:

A director of a company must act in the way he considers, in good faith, would be most likely to promote the success of the Company for the benefit of its members as a whole, and in doing so have regard (amongst other matters) to:

a) The likely consequences of any decision in the long term;
b) The interest of the Company’s employees;
c) The need to foster the Company’s business relationships with suppliers, customers and others;
d) The impact of the Company’s operations on the community and the environment;
e) The desirability of the Company maintaining a reputation for high standards of business conduct; and
f) The need to act fairly as between members of the Company.

There are no separate company only matters to be disclosed.

Customers
The Board initiates the design, implementation and regular review of a platform of care that promotes the welfare of animals we treat, adhering to all relevant national legislation. Customers expect the highest clinical standards and care to be observed.When a clinic joins IVC Evidensia, its staff are trained in safety and clinical standards to ensure animals receive care of a consistently high standard. The IVC Evidensia Hygiene Booklet was created by the Board to ensure hygiene safety in the clinics is maintained at consistently high levels.

To ensure clinical excellence across the Group, Clinical Boards are established in each country the Group operates in, which review clinical procedures and ensure clinical guidance reflects best practice. These country boards are overseen by the Group Veterinary Medical Board. This guides the Group on matters of ethics or professional standards, making recommendations on matters such as laboratory quality, education, hygiene,
anti-microbial resistance and professional conduct, as well as promoting an exchange of ideas between countries.

During the year, the Board communicates with its customers by receiving updates on key customer issues at its regular board meetings and members of the Board attend site visits so they can hear first-hand about customer concerns. The Board also reviews customer feedback through social media channels, surveys and mail and this helps to inform its actions. For example, IVC Evidensia tracks and scores highly in customer net promoter score surveys (Score:94) and in customer 'Onswitch' surveys. Based on these communications, the Board takes appropriate actions to make sure its customers are in its highest regard such as the nutrition programme based on consumer feedback mentioned below.

This year, the Board reluctantly took a decision to temporarily close a limited number of vet practices during the main period of the Covid-19 pandemic, for the safety of customers and our own staff. Social distancing policies, additional protective personal equipment was sourced and provided to all surgeries, and other safety measures were implemented before clinics were re-opened. (see Other Stakeholders section below for more detail). Other decisions that show the Board have the highest regard for its customers include the adoption of a new nutrition programme this year to support improved health of customers’ pets. Insurance initiatives and healthcare plans, such as the Pet Health Club in the UK, are also offered to customers to help provide visibility of costs throughout the year.

Recently IVC Evidensia launched a Care Fund, to assist customers who could not otherwise afford lifesaving treatment for their animal. This not only protects animal welfare it also protects the well-being of our customers and staff by providing support to an often challenging and immensely stressful decision making process. This was introduced following feedback from staff and, in turn, from customers.
 

 

IVC Acquisition Ltd

Strategic Report for the Year Ended 30 September 2020 (continued)

Employees
The ethical statement commits the Group to provide a safe, happy and secure work environment where we treat all our people with care, respect, empathy and kindness.

Vets joining IVC Evidensia gain access to regular training, clinical guidance and are supported in health and safety, human resources, finance and marketing activities. This enables them to focus on the clinical aspects of their work, and for many this is a key motivation in joining IVC Evidensia. The Board takes their interests into account by making vets part of a professional network of clinics, providing training via the IVC Evidensia Academy and setting standards via the in-country clinical boards.

The Board had employees’ and customers’ safety interests as its highest priority during the Covid 19 pandemic. Safety equipment was quickly put in place, clinical operating procedures were changed, and support provided so that office staff could work from home. The Group complies with the local statutory guidance on managing the risk of Covid-19and carried out a Covid-19 risk assessment. Cleaning, hand washing and hygiene procedures are all performed in line with that guidance and the Board has taken all reasonable steps to help people work from home and maintain social distancing in the office or practice workplaces. The Board acted swiftly by furloughing staff where required to protect their roles for the future during periods of reduced activity.

The Board also showed its commitment to the mental wellbeing of staff by developing a mental health strategy in conjunction with Mental Health First Aid England. A Wellbeing week held in November 2019 was highly successful with mass staff participation at the support centre in Keynsham, UK. Support for the LGBT+ community within the Group is provided through wellbeing champions and the Company also makes a counselling service available to all employees.

The Board communicates key messages and Group performance with its staff through monthly meetings where questions are asked by employees and via bi-weekly video newsletters sent to all employees. In addition, there are regular meetings coordinated throughout the group, based on areas of interest or specialism, for example the farm animal clinical directors meetings. This gives clinicians an opportunity to share experience and best practice. Based on these communications, the Board changes staff policy appropriately.
 

Suppliers
The Board is committed to the fair treatment of suppliers and is committed to paying within agreed terms of credit. Operations teams build strong relationships with our suppliers to develop mutually beneficial and lasting partnerships, engaging through regular interactions and formal reviews.

The Board recognises that relationships with suppliers are important to the Group’s long-term success. It communicates with them by being briefed on supplier feedback and issues on a regular basis. Based on these communications, the Board adjusts certain practices with suppliers in order to improve its supply chain. Our ethical statement prohibits engagement with corruption or bribery, and a zero-tolerance policy towards suppliers
is taken with this.

Environment
The ethical statement commits the board to act and implement procedures that minimise the impact our business has on the environment and to develop relationships with suppliers who share this ideal. This was shown, to a great extent, in Sweden where the business has committed to not only being carbon neutral, but “climate-positive”.

The Group set up a “Green Team” in its support centre in the UK which looks at initiatives to reduce the Group’s carbon footprint and improve the environment. Examples of initiatives introduced include encouraging staff to join community litter picking activities and the sharing of vegan recipes to help staff reduce their carbon footprint through their diet.
 

 

IVC Acquisition Ltd

Strategic Report for the Year Ended 30 September 2020 (continued)

Community
The Board takes the interests of the community and its social responsibility very seriously. This is illustrated to a global extent when the Group provided a quick response to the Australian bush fires in January 2020, taking a decision to fully fund teams of our own vets and nurses to work in Australia to aid wildlife recovery.

Nearer to home, the Group considers the social impact its business has on local communities and puts in policies and strategies in relation to this. At the UK support centre in Keynsham, local animal charities are supported with frequent fund-raising activities. In Finland, the Evidensia Rauma clinic agreed to neuter cats at the local animal shelter for cost price, thereby making them suitable for adoption. In addition to providing direct employment to
c.20K people, IVC Evidensia has invested in its Vets Graduate Academy, with an intake this year of 400, and its Nurse Academy.

The Board communicates with its community through senior management attending local community forums such as the Somerdale community forum at its support centre at Keynsham. This has led to the Board changing its policies in the community such as local fund raisers.
 

Investors
The Group is funded by a mixture of equity and loan finance, meaning the Board has to consider the interests of both shareholders and lenders. The Board is committed to providing its stakeholders with sustainable, profitable growth over the longer term. This is underpinned by the Group’s highly acquisitive strategy. During the year the Board took the decision to refresh the groups Revolving Credit Facility, thereby providing funding for future
acquisitions whilst maintaining liquidity for protection of the business through the pandemic, ensuring the Group had sufficient cash and working capital.

Encouraging practices to join the Group’s network increases its purchasing power and economies of scale, allowing investment into existing and new surgeries. The Group can then offer customers access to a greater range of treatments. In addition, this creates increased shareholder returns. The Board has expanded into new countries such as Belgium this year and also invested in new veterinary areas such as the large France hospital
acquisition (Fregis) to unlock new markets and develop revenue streams.

The Board also made the difficult decision undertaking a limited scope redundancy programme in its UK support office.

The Group has an open dialogue with shareholders and lenders through email communication, individual and Group meetings. Discussions cover a wide range of topics including financial performance, strategy, outlook, governance and ethical practices.

Government and regulators
The Group regularly interacts with local governments and regulators in each market to ensure animal safety is maintained in the Group’s practices.

The Group regularly communicates with the respective regulators in a variety of ways through its Group Veterinary Medical Board and national Clinical Boards in each market.

 

IVC Acquisition Ltd

Strategic Report for the Year Ended 30 September 2020 (continued)

Illustration of how the Board considers all stakeholder views in its acquisition strategy
The Group has continued its highly acquisitive strategy this year by purchasing another 230 sites. The Group had 1,331 sites at the start of the year and now has 1,536 sites across the UK, Ireland and Mainland Europe, also taking into account 25 closures in the year. The Board considers all stakeholders’ interests as part of its acquisition strategy.

Employees benefit through the acquisition strategy. Employees have access to a professional network with high quality training and this can be achieved by being part of a bigger group. In addition, as the Group increases its economies of scale, further investment can be made into existing surgeries, increasing the range of treatment made available. Customers want their pet to have the highest care possible and this is achieved by bringing sites into the group where vets can access the highest safety and hygiene standards as well as access to more referral centres. This means that the customer can get high quality care by sending their pet to a vet in a larger network.

Suppliers can also benefit from the Group’s acquisition strategy. They want to access more vets and can achieve higher volumes by the Group acquiring further sites. Investors seek a return on their investment, and this is in part achieved by purchasing more sites and increasing the scale of operations.
 

Approved by the Board on 1 June 2021 and signed on its behalf by:

.........................................
M A Gillings
Director

 

IVC Acquisition Ltd

Directors' Report for the Year Ended 30 September 2020

The directors present their report and the financial statements for the year ended 30 September 2020.

Directors of the company

The directors who held office during the year and to the date of signing were as follows:

S M Clarke (appointed 12 May 2020)

P G Franzen

M A Gillings

P M Kenyon (appointed 24 January 2020)

A Reza

D R G Hillier (resigned 2 March 2020)


Dividends
The directors do not propose a dividend in the current year or prior year.

Directors’ insurance
The company maintains insurance policies on behalf of all directors against liability arising from negligence, breach of duty and breach of trust in relation to the company.

Future developments
The company plans to continue with its strategy of acquiring high quality veterinary practices. The company has funding facilities in place to fund the planned acquisitions. The company is strongly cash generating before investing in additional acquisitions.

Financial risk management objectives and policies

Objectives and policies
The board constantly monitors the company’s trading results and revise the projections as appropriate to ensure that the company can continue to meet its future obligations as they fall due.

Price risk, credit risk, liquidity risk and cash flow risk
The company is exposed to the usual credit and cash flow risk associated with selling on credit and manages this through credit control procedures.

Credit risk in respect of bank balances is safeguarded by using banks with high credit ratings.

Engagement with suppliers, customers and other
For more detail on how the Group engages with its suppliers and customers, refer to the Section 172 (1) statement on page 4.

Going concern

Going concern has been considered in the strategic report on page 3. There are no specific post balance sheet events for this company.

Important non adjusting events after the financial period

On 9 February 2021 it was announced that, as part of its long-term commitment to IVC, EQT Private Equity is making a substantial 15% investment through its EQT IX fund, and with the transaction EQT VII fund is partially exiting its stake but will remain invested in the company. In addition, Silver Lake, a leading global technology investment firm, will be making a new 15% minority investment in IVC to help further unlock and accelerate growth from digital and technology opportunities. Lastly, Nestlé, which joined EQT Private Equity in 2019 as a minority investor and strategic partner, is also increasing its minority stake in IVC by 5% as part of this transaction. The transaction completed on 25 May 2021.

Also as part of this transaction, Islay New Group Holding SA, a company registered in Luxembourg acquired the entire shareholding of IVC New Top Holding S.A. (an indirect parent company of the Company) which was controlled by Browne Holding S.à.r.l. As no shareholder owns more than 50% of Islay New Group Holding SA, Islay New Group Holding SA became the new ultimate parent company from 25 May 2021.

 

IVC Acquisition Ltd

Directors' Report for the Year Ended 30 September 2020 (continued)

Disclosure of information to the auditor

Each of the persons who is a director at the date of approval of this report confirms that:
• so far as the director is aware, there is no relevant audit information of which the Company's auditor is unaware; and
• the director has taken all the steps that they ought to have taken as a director in order to make themselves aware of any relevant audit information and to establish that the company's auditor is aware of that information.

This confirmation is given and should be interpreted in accordance with the provisions of s418 of the Companies Act 2006.

Reappointment of auditor

Deloitte LLP have expressed their willingness to continue in office and appropriate arrangements are being made for them to be deemed reappointed as auditor in the absence of an Annual General Meeting.

Approved by the Board on 1 June 2021 and signed on its behalf by:

.........................................
M A Gillings
Director

 

IVC Acquisition Ltd

Statement of Directors' Responsibilities

The directors are responsible for preparing the Annual Report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law), including FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland". Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

select suitable accounting policies and then apply them consistently;

make judgements and accounting estimates that are reasonable and prudent;

state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

 

IVC Acquisition Ltd

Independent Auditor's Report to the Members of IVC Acquisition Ltd

Report on the audit of the financial statements


Opinion
In our opinion the financial statements of IVC Acquisition Ltd (the ‘company’):

give a true and fair view of the state of the company’s affairs as at 30 September 2020 and of its loss for the year then ended;

have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice, including Financial Reporting Standard 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland”; and

have been prepared in accordance with the requirements of the Companies Act 2006.

We have audited the financial statements which comprise:

the profit and loss account;

the balance sheet;

the statement of changes in equity;

the related notes 1 to 22.

The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (United Kingdom Generally Accepted Accounting Practice).

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor's responsibilities for the audit of the financial statements section of our report.

We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the Financial Reporting Council’s (the ‘FRC’s’) Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

We are required by ISAs (UK) to report in respect of the following matters where:

• the directors’ use of the going concern basis of accounting in preparation of the financial statements is not appropriate; or
• the directors have not disclosed in the financial statements any identified material uncertainties that may cast significant doubt about the company’s ability to continue to adopt the going concern basis of accounting for a period of at least twelve months from the date when the financial statements are authorised for issue.

We have nothing to report in respect of these matters.

Other information

 

IVC Acquisition Ltd

Independent Auditor's Report to the Members of IVC Acquisition Ltd (continued)

The directors are responsible for the other information. The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in respect of these matters.

 

IVC Acquisition Ltd

Independent Auditor's Report to the Members of IVC Acquisition Ltd (continued)

Responsibilities of directors

As explained more fully in the Statement of Directors’ Responsibilities, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor’s responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

A further description of our responsibilities for the audit of the financial statements is located on the FRC’s website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.

Report on other legal and regulatory requirements

Opinion on other matter prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

the information given in the Strategic Report and Directors' Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

the Strategic Report and Directors' Report have been prepared in accordance with applicable legal requirements.

In the light of our knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report and the Directors' Report.

Matters on which we are required to report by exception

Under the Companies Act 2006 we are required to report in respect of the following matters if, in our opinion:

adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

the financial statements are not in agreement with the accounting records and returns; or

certain disclosures of directors’ remuneration specified by law are not made; or

we have not received all the information and explanations we require for our audit.

We have nothing to report in respect of these matters.

Use of this report
This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

......................................
Andrew Wright (Senior statutory auditor)
For and on behalf of Deloitte LLP
Statutory Auditor
Bristol, United Kingdom

1 June 2021

 

IVC Acquisition Ltd

Profit and Loss Account for the Year Ended 30 September 2020

Note

2020
 £ 000

2019
 £ 000

Turnover

3

8,726

6,301

Administrative expenses

 

(13,680)

(12,810)

Operating loss

4

(4,953)

(6,509)

Other interest receivable and similar income

8

80,302

59,834

Interest payable and similar charges

9

(153,515)

(149,362)

Loss before tax

 

(78,166)

(96,037)

Taxation

10

-

-

Loss for the financial year

 

(78,166)

(96,037)

The above results were derived from continuing operations.

The company has no other comprehensive income for the year or the previous year. Accordingly, no statement of comprehensive income has been presented.

 

IVC Acquisition Ltd

(Registration number: 10505083)
Balance Sheet as at 30 September 2020

Note

2020
 £ 000

(As restated see note 2)
2019
 £ 000

Fixed assets

 

Tangible assets

11

801

527

Investments

12

658,614

651,020

 

659,415

651,547

Current assets

 

Debtors: Amounts falling due within one year

13

30,367

27,804

Cash at bank and in hand

 

15,230

149,802

 

45,597

177,606

Creditors: Amounts falling due within one year

14

(777,555)

(729,591)

Net current liabilities

 

(731,958)

(551,985)

Debtors: Amounts falling due after more than one year

13

1,879,489

1,503,148

Total assets less current liabilities

 

1,806,946

1,602,710

Creditors: Amounts falling due after more than one year

14

(1,525,787)

(1,248,534)

Net assets

 

281,159

354,175

Capital and reserves

 

Called up share capital

16

9,568

9,568

Share premium account

645,599

569,178

Consideration received for shares to be issued

-

71,271

Profit and loss account

(374,008)

(295,842)

Total equity

 

281,159

354,175

Approved and authorised by the Board on 1 June 2021 and signed on its behalf by:
 

.........................................

M A Gillings
Director

 

IVC Acquisition Ltd

Statement of Changes in Equity for the Year Ended 30 September 2020

Share capital
£ 000

Share premium
£ 000

Consideration received for shares to be issued
£ 000

Profit and loss account
£ 000

Total
£ 000

At 1 October 2019 (as previously stated)

9,568

640,449

-

(295,842)

354,175

Prior period adjustment

-

(71,271)

71,271

-

-

At 1 October 2019 (As restated see note 2)

9,568

569,178

71,271

(295,842)

354,175

Loss for the year

-

-

-

(78,166)

(78,166)

New share capital subscribed

-

5,150

-

-

5,150

Issue of share capital from prior year contribution

-

71,271

(71,271)

-

-

At 30 September 2020

9,568

645,599

-

(374,008)

281,159

Share capital
£ 000

Share premium
£ 000

Consideration received for shares to be issued
£ 000

Profit and loss account
£ 000

Total
£ 000

At 1 October 2018

9,568

300,416

-

(199,805)

110,179

Loss for the year

-

-

-

(96,037)

(96,037)

New share capital subscribed (As restated see note 2)

-

268,762

71,271

-

340,033

At 30 September 2019

9,568

569,178

71,271

(295,842)

354,175

 

IVC Acquisition Ltd

Notes to the Financial Statements for the Year Ended 30 September 2020

 

1

General information

The company is a private company limited by share capital, incorporated and registered in England and Wales.

The address of its registered office is:
The Chocolate Factory
Keynsham
Bristol
BS31 2AU

 

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements were prepared in accordance with Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'. The group has early adopted the ‘Amendments to FRS 102’ published in December 2017 in preparing these financial statements and they do not expect this to impact the financial statements.

Cash flow exemption
The company has not presented a cash flow statement on the grounds that the company’s cash flows are included in the financial statements of the consolidated financial statements of its ultimate parent undertaking in the UK, IVC Acquisition Pikco Limited.

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest thousand.

The company meets the definition of a qualifying entity under FRS 102 and has therefore taken advantage of the disclosure exemptions available to it in respect of its separate financial statements. Exemptions have been taken in relation to financial instruments, related party transactions, presentation of a cash flow statement and remuneration of key management personnel.

Name of parent of group

These financial statements are consolidated in the financial statements of the company's immediate parent company, IVC Acquisition Midco Limited, and in the financial statements of IVC Acquisition Pikco Limited, a parent company.

The financial statements of IVC Acquisition Midco Limited and IVC Acquisition Pikco Limited may be obtained from Companies House.

 

IVC Acquisition Ltd

Notes to the Financial Statements for the Year Ended 30 September 2020 (continued)

 

2

Accounting policies (continued)

Going concern

The financial statements include details of the financial position of the Company, its liquidity position and borrowing.

The Company is part of the IVC Evidensia Group (“the Group”) in which a detailed going concern assessment has been made. The Group meets its day-to-day working capital requirements through operating cash flows and its acquisition requirements through senior debt facilities. The Group’s forecasts and projections, covering a period of at least 12 months from the approval of these financial statements, show that the Group should be able to operate within the level of its current debt facilities. After taking account of reasonably possible changes in trading performance, no material uncertainty exists regarding covenant compliance on the Group’s existing facilities.

As part of the going concern assessment, the Group modelled various scenarios including the impact of reasonable possible changes related to the Covid-19 pandemic. These reflected the learnings and changes implemented as a result of the pandemic thus far and Government initiatives or grants were assumed to be unavailable. It was assumed that the impact will be less severe than the first wave, as, since that point in time:

• The industry regulators have accepted that the veterinary sector is an essential service so restrictions on services would be minimal.
• Clinics would remain open having the personal, protective equipment they need and having tried and tested alternative working procedures in place.
• Following the first national lock down that ended in July 2020, the Group has seen no significant impact on revenue in areas which have been subject to subsequent local lock downs, indicating that the actions taken by the Group, and the reaction of customers, has been such that trading at or above pre-lock down levels will continue despite further lock downs.

The sensitivities applied were as follows:

• impact of Brexit in the form of delays in receiving inventory;
• increase in bank interest rates by 1%;
• a devaluation of GBP vs Swedish Krona/Euro by 10%; and
• a reduction of revenue corresponding to 25% of FY20 revenue with a reduction in Gross profit at the same margin as FY20 and assuming no additional Covid-19 initiatives are available.

The sensitivity analyses showed that the Group and therefore the Company would still have sufficient cash flows to allow it to service the Company and its’ subsidiaries’ debt and settle trading liabilities, and comply with covenant requirements under its banking facilities for a period of at least 12 months from the date of signing of the financial statements.

The directors therefore have a reasonable expectation that the Group and therefore the Company has adequate resources to continue in operational existence for the foreseeable future. Accordingly, they continue to adopt the going concern basis of accounting in preparing the annual financial statements.

Exemption from preparing group accounts

The financial statements contain information about IVC Acquisition Ltd as an individual company and do not contain consolidated financial information as the parent of a group.

The company is exempt under section 400 of the Companies Act 2006 from the requirement to prepare consolidated financial statements as it and its subsidiary undertakings are included by full consolidation in the consolidated financial statements of its parent, IVC Acquisition Midco Limited, a company incorporated in England and Wales. The address of IVC Acquisition Midco Limited's registered office is The Chocolate Factory, Keynsham, Bristol, BS31 2AU.

 

IVC Acquisition Ltd

Notes to the Financial Statements for the Year Ended 30 September 2020 (continued)

 

2

Accounting policies (continued)

Restatement of comparative amounts

During the 30 September 2020 financial year end, an exercise was undertaken to review intercompany agreements and balances in the IVC Evidensia group. It was discovered that certain intercompany balances had been incorrectly classified in the 2019 financial statements between non-current and current. This has now been restated accordingly as shown below. These changes do not change the reported net assets or profits of the Company in 2019.

On 6 November 2019 the Company subscribed 1 share for £1 to IVC Acquisition Midco Limited for a consideration of £71,271,489. However, the cash was received from the parent undertaking on 6 September 2019. There was no obligation for the Company to repay the cash received to the parent undertaking and it was understood by all parties that this was advanced consideration for the future share issuance that yet required final board approval. Therefore, the amount has been recorded as a consideration received for shares to be issued in the year ended 30 September 2019. This is different to the 2019 financial statements where this amount was recorded as share premium. The amount has been restated accordingly.

Amount reported at 30 September 2019

Error identified

Amount restated at 30 September 2019

£000

£000

£000

Debtors

Amounts owed by group undertakings - amounts falling due after more than one year

-

1,503,148

1,503,148

Amounts owed by group undertakings - amounts falling due within one year

1,530,332

(1,503,145)

27,187

1,530,332

3

1,530,335

Creditors

Amounts owed by group undertakings - amounts falling due after more than one year

766,323

(719,145)

47,178

Amounts owed by group undertakings - amounts falling due within one year

-

719,148

719,148

766,323

3

766,323

Equity

Share premium

640,449

(71,271)

569,178

Consideration received for shares to be issued

-

71,271

71,271

640,449

-

640,449

 

IVC Acquisition Ltd

Notes to the Financial Statements for the Year Ended 30 September 2020 (continued)

 

2

Accounting policies (continued)

Critical accounting judgements and key sources of estimation uncertainty
In the application of the Company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.

Critical judgements in applying the Company’s accounting policies
There are no critical judgements, apart from those involving estimations (which are dealt with separately below), that the directors have made in the process of applying the Company’s accounting policies and that have the most significant effect on the amounts recognised in the financial statements.

Key source of estimation uncertainty
There are no key sources of estimation uncertainty at the end of the reporting period that may have a significant risk of causing a material adjustment to the carrying amounts of the assets and liabilities within the next financial year.

Revenue recognition

Turnover represents management charges invoiced to subsidiaries.

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the company and the revenue can be reliably measured. The revenue recognition point is when a veterinary consultation, a veterinary procedure or a cremation is completed. Sales of goods are recognised when goods are dispatched and title has passed; for example, on-line sales are recognised when the goods are dispatched from the warehouse. Revenue is measured at the fair value of the consideration received or receivable, excluding value added tax and discounts.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in the profit and loss account, except that a charge attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income. The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Intangible assets

Intangible assets are stated in the balance sheet at cost, less any subsequent accumulated amortisation and subsequent accumulated impairment losses.

The cost of intangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

 

IVC Acquisition Ltd

Notes to the Financial Statements for the Year Ended 30 September 2020 (continued)

 

2

Accounting policies (continued)

Amortisation

Amortisation is charged so as to write off the cost of assets, over their estimated useful lives, as follows:

Asset class

Amortisation method and rate

Software development costs

Straight-line over 3 years

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.

Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Foreign currency transactions and balances

Any balances denominated in a foreign currency within the company have been translated at the closing rate into sterling.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and all are repayable within one year and hence are included at the undiscounted amount of cash expected to be paid.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the Profit and Loss Account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

IVC Acquisition Ltd

Notes to the Financial Statements for the Year Ended 30 September 2020 (continued)

 

2

Accounting policies (continued)

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

Financial instruments

Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.

 Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

Interest revenue is subsequently carried at amortised cost using the effective interest rate method, less provision for impairment.

Impairment
For financial assets carried at amortised cost, the amount of an impairment is the difference between the asset’s carrying amount and the present value of estimated future cash flows, discounted at the financial asset’s original effective interest rate.

For financial assets carried at cost less impairment, the impairment loss is the difference between the asset’s carrying amount and the best estimate of the amount that would be received for the asset if it were to be sold at the reporting date.

Where indicators exist for a decrease in impairment loss, and the decrease can be related objectively to an event occurring after the impairment was recognised, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired financial asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised.

 

3

Revenue

The analysis of the company's revenue for the year from continuing operations is as follows:

2020
£ 000

2019
£ 000

Intercompany recharges

8,726

6,301

The analysis of the company's turnover for the year by market is as follows:

 

IVC Acquisition Ltd

Notes to the Financial Statements for the Year Ended 30 September 2020 (continued)

 

3

Revenue (continued)

2020
£ 000

2019
£ 000

UK

8,726

6,301

 

4

Operating loss

Arrived at after charging:

2020
 £ 000

2019
 £ 000

Depreciation expense

66

-

 

5

Auditor's remuneration

2020
£ 000

2019
£ 000

Audit of the financial statements

1,200

1,053

 

IVC Acquisition Ltd

Notes to the Financial Statements for the Year Ended 30 September 2020 (continued)

 

6

Staff costs

The aggregate payroll costs (including directors' remuneration) were as follows:

2020
 £ 000

2019
 £ 000

Wages and salaries

4,470

1,583

Social security costs

341

171

Pension costs, defined contribution scheme

25

29

Other employee expense

4

1

 

4,840

1,784

The monthly average number of persons employed by the company (including directors) during the year, analysed by category was as follows:

2020
 No.

2019
 No.

Directors and key management

10

5

 

7

Directors' remuneration

The directors' remuneration for the year was as follows:

2020
£ 000

2019
£ 000

Remuneration (including benefits in kind)

2,001

1,107

Contributions paid to money purchase schemes

8

16

2,009

1,123

During the year the number of directors who were receiving benefits was as follows:

2020
No.

2019
No.

Accruing benefits under money purchase pension scheme

1

3

In respect of the highest paid director:

2020
£ 000

2019
£ 000

Remuneration (including benefits in kind)

669

481

Company contributions to money purchase pension schemes

-

4

 

8

Other interest receivable and similar income

2020
£ 000

2019
£ 000

Interest from group companies

80,070

59,761

Interest income on bank deposits

232

73

80,302

59,834

 

IVC Acquisition Ltd

Notes to the Financial Statements for the Year Ended 30 September 2020 (continued)

 

9

Interest payable and similar expenses

2020
£ 000

2019
£ 000

Interest on bank overdrafts and borrowings

67,627

55,759

Interest payable to group companies

79,553

73,805

Finance costs adjacent to interest

7,879

13,574

Foreign exchange (gains) / losses

(1,544)

6,224

153,515

149,362

 

10

Taxation

The tax on loss before tax for the year is higher than the standard rate of corporation tax in the UK (2019 - higher than the standard rate of corporation tax in the UK) of 19% (2019 - 19%).

The differences are reconciled below:

2020
£ 000

2019
£ 000

Loss before tax

(78,166)

(96,037)

Corporation tax at standard rate

(14,852)

(18,247)

Effect of expense not deductible in determining taxable profit (tax loss)

-

672

Tax increase arising from group relief

14,852

17,575

Total tax charge/(credit)

-

-

 

11

Tangible assets

Software development costs
 £ 000

Cost

At 1 October 2019

527

Additions

340

At 30 September 2020

868

Depreciation

At 1 October 2019

-

Charge for the year

66

At 30 September 2020

66

Carrying amount

At 30 September 2020

801

At 30 September 2019

527

 

IVC Acquisition Ltd

Notes to the Financial Statements for the Year Ended 30 September 2020 (continued)

 

12

Investments in subsidiaries

2020
£ 000

2019
£ 000

Investments in subsidiaries

658,614

651,020

Subsidiaries

£ 000

Cost

At 1 October 2019

651,020

Additions

7,594

At 30 September 2020

658,614

Carrying amount

At 30 September 2020

658,614

At 30 September 2019

651,020

Additions in the year related to the £4,646,000 recapitalisation of Evidensia France SAS and the £2,948,000 recapitalisation of Evidensia Belgium BVBA, both completed on 21 September 2020.

Details of undertakings

Details of the investments in which the company holds 20% or more of the nominal value of any class of share capital are as follows:

Undertaking

Registered office

Holding

Proportion of voting rights and shares held

     

2020

2019

Subsidiary undertakings

IVC Topco Limited

Ordinary

100%

100%

 

Jersey

     

Evidensia Holding AB

Ordinary

100%

100%

 

Sweden

     

Independent Vetcare Limited

Ordinary

100%

100%

 

England and Wales

     

Advanced Vetcare Limited

Ordinary

100%

100%

 

England and Wales

     

Berry House Limited

Ordinary

100%

100%

 

England and Wales

     

PDOL Limited

Ordinary

100%

100%

 

England and Wales

     

Evidensia Belgium BVBA

Ordinary

100%

100%

 

Belgium

     

Evidensia France SAS

Ordinary

100%

100%

 

France

     

Independent Vetcare Ireland

Ordinary

100%

100%

 

Ireland

     
 

IVC Acquisition Ltd

Notes to the Financial Statements for the Year Ended 30 September 2020 (continued)

 

12

Investments in subsidiaries (continued)

The principal activity of Independent Vetcare Limited and Evidensia Holding AB is the provision of veterinary services. The principal activity of all other companies was that of dormant companies.

The company also owns a number of other trading subsidiaries indirectly via Independent Vetcare Limited and Evidensia Holding AB, details of which are recorded in Note 22.

The registered office for all companies registered in England and Wales is The Chocolate Factory, Keynsham, Bristol, BS31 2AU. The registered office for all companies registered in Scotland is 58 Argyle Street, Inverness, IV2 3BB. The registered office for all companies registered in Northern Ireland is 133 Galgorm Road, Ballymena, BT42 1DE. The registered office for all companies registered in the Isle of Man is 33-37 Athol Street, Douglas, Isle of Man, IM1 1LB.

 

13

Debtors

2020
 £ 000

(As restated)
2019
 £ 000

Other debtors

339

532

Prepayments

61

85

Amounts owed by group undertakings

1,909,456

1,530,335

 

1,909,856

1,530,952

Less amounts falling due after more than one year

(1,879,489)

(1,503,148)

Total debtors: amounts falling due within one year

30,367

27,804

Details of debtors: amounts falling due after more than one year

£1,879M (2019 - £1,503M) of amounts owed by group undertakings are secured and classified as due after more than one year. Interest of 4.7% per annum is earned on these amounts.

 

14

Creditors

Note

2020
 £ 000

(As restated)
2019
 £ 000

Due within one year

 

Trade creditors

 

181

367

Amounts owed to group undertakings

 

748,891

719,148

Social security and other taxes

 

141

68

Outstanding defined contribution pension costs

 

-

4

Other creditors

 

114

-

Accrued expenses

 

28,227

10,004

   

777,555

729,591

Due after one year

 

Loans and borrowings

15

1,374,521

1,201,357

Amounts owed to group undertakings

 

151,266

47,178

 

1,525,787

1,248,534

 

IVC Acquisition Ltd

Notes to the Financial Statements for the Year Ended 30 September 2020 (continued)

 

14

Creditors (continued)

£749M (2019 - £719M) of amounts owed to group undertakings are secured, re-payable on demand and carry interest at 4% - 4.7% per annum. £1,375M (2019 - £1,201M) of amounts owed to group undertakings are secured, classified as non current and carry interest at 4% - 4.7%.

 

15

Loans and borrowings

2020
£ 000

2019
£ 000

Non-current loans and borrowings

Bank borrowings

1,374,521

1,201,357

Total bank loans outstanding of £1,375M (2019 - £1,201M) (after deducting £19M (2019 - £20M)) of costs associated with the raising of this finance which are being released to the profit and loss accounts over the term of the debt; i.e. total bank debt was £1,394M (2019 - £1,221M) at 30 September 2020 are repayable in 2025. The rate of interest on each loan for each interest period is the percentage rate per annum, which is the aggregate of the applicable margin and LIBOR as the case may be (between 3.75% and 5.22%). Interest is paid in instalments at intervals left to the Company's discretion, subject to the group’s compliance with banking covenants.

The Company is bound by an intra-group cross guarantee in respect of bank debt with other members of the Group. The amount guaranteed at 30 September 2020 is £1,394M (2019 - £1,221M) and is secured by a debenture over the assets and undertakings of certain companies in the Group.
 

 

16

Share capital

Allotted, called up and fully paid shares

 

2020

2019

 

No. 000

£ 000

No. 000

£ 000

Ordinary shares of £0.01 each

359,432

3,594

359,432

3,594

Ordinary shares of £1 each

5,974

5,974

5,974

5,974

 

365,406

9,568

365,406

9,568

New shares allotted

During the year, 1 Ordinary share having an aggregate nominal value of £1 was allotted for an aggregate consideration of £5,150,000.

Issue of share capital from prior year contribution
During the year, the Company issued 1 ordinary share having an aggregate nominal value of £1 for a value of £71,271,489. The amount was paid down to the Company on 6 September 2019, but not issued until 6 November 2019 (see page 18 for more details).

Rights, preferences and restrictions

The different classes of share referred to above carry separate rights to dividends but, in all other significant respects, rank pari passu.

 

IVC Acquisition Ltd

Notes to the Financial Statements for the Year Ended 30 September 2020 (continued)

 

17

Reserves

Share premium account
Includes any premiums received on issue of share capital. Any transaction costs associated with the issuing of shares are deducted from share premium.

Consideration received for shares to be issued
Represents premiums received on issue of share capital where the shares are yet to be issued.

Capital redemption reserve
Represents the amount that the company has transferred to the profit and loss account and is required to retain as a result of repurchasing its own shares. It is a non-deductible reserve.

Profit and loss account
Includes all current and prior periods retained profit and losses.

 

IVC Acquisition Ltd

Notes to the Financial Statements for the Year Ended 30 September 2020 (continued)

 

18

Pension and other schemes

Defined contribution pension scheme

The company operates a defined contribution pension scheme. The pension cost charge for the year represents contributions payable by the company to the scheme and amounted to £25,165 (2019 - £29,364).

Contributions totalling £Nil (2019 - £3,576) were payable to the scheme at the end of the year and are included in creditors.

 

19

Parent and ultimate parent undertaking

The company is controlled by IVC Acquisition Midco Limited, incorporated in England and Wales. The ultimate parent undertaking at the financial year end was Browne Holding S.à.r.l., a company registered in Luxembourg. On 25 May 2021, Islay New Group Holding SA, a company registered in Luxembourg acquired the entire shareholding of IVC New Top Holding S.A.(an indirect parent company of the Company) which was controlled by Browne Holding S.à.r.l. As no shareholder owns more than 50% of Islay New Group Holding SA, Islay New Group Holding SA became the new ultimate parent company from 25 May 2021.

The parent of the largest group in which these financial statements are consolidated is IVC Acquisition Pikco Limited, incorporated in England and Wales.

The address of IVC Acquisition Pikco Limited is:
The Chocolate Factory
Keynsham
Bristol
BS31 2AU

The parent of the smallest group in which these financial statements are consolidated is IVC Acquisition Midco Limited, incorporated in England and Wales.

The address of IVC Acquisition Midco Limited is:
The Chocolate Factory
Keynsham
Bristol
BS31 2AU

The address of the smallest and largest subsidiary undertakings are the same as above.

 

IVC Acquisition Ltd

Notes to the Financial Statements for the Year Ended 30 September 2020 (continued)

 

20

Non adjusting events after the financial period

On 20 April 2021, the Company refinanced its loans and borrowings. The Company drew down additional borrowing on a new B3 Facility (GBP) and B4 Facility (EUR) that amounted to £219m and £318m respectively. This was used to repay the drawn down revolving credit facility of £185m plus interest of £1m. Fees associated with refinancing amounted to £5m and the additional borrowing was used to pay these. The funds were also used to repay existing B2 Facility lenders who wished to exit and this amounted to £96m.

Additionally, the funds were used to repay the Payment In Kind debt in one of the Company’s parent undertakings, IVC Acquisition Pikco Limited which amounted to £232m at this date. The amounts owed to group undertakings reduced by £232m because of this. The remainder of the unused additional borrowing was received in Cash of £17m.

Subsequently the B1 Facility (GBP) £602m and the remaining B2 Facility (EUR) £430m were merged into the new B3 Facility (GBP) and B4 Facility (EUR) resulting in total loan values at 20 April 2021 of B3 Facility (GBP) £821m and B4 Facility (EUR) £748m. A new revolving credit facility was also agreed and this was undrawn at £348m.

On 9 February 2021 it was announced that, as part of its long-term commitment to IVC, EQT Private Equity is making a substantial 15% investment through its EQT IX fund, and with the transaction EQT VII fund is partially exiting its stake but will remain invested in the company. In addition, Silver Lake, a leading global technology investment firm, will be making a new 15% minority investment in IVC to help further unlock and accelerate growth from digital and technology opportunities. Lastly, Nestlé, which joined EQT Private Equity in 2019 as a minority investor and strategic partner, is also increasing its minority stake in IVC by 5% as part of this transaction. The transaction completed on 25 May 2021.

Also as part of this transaction, Islay New Group Holding SA, a company registered in Luxembourg acquired the entire shareholding of IVC New Top Holding S.A. (an indirect parent company of the Company) which was controlled by Browne Holding S.à.r.l. As no shareholder owns more than 50% of Islay New Group Holding SA, Islay New Group Holding SA became the new ultimate parent company from 25 May 2021.

 

21

Related party transactions

The company has taken advantage of the exemption available and has not disclosed transactions with the ultimate parent company or any wholly owned subsidiary of the group.

 

22

List of companies

Subsidiary undertakings

Country of incorporation

Class

2020 shares held %

2019 shares held %

Evidensia Belgium BVBA

Belgium

Ordinary

100

100

Sanimalia Services BV

Belgium

Ordinary

99

-

VVD Services BV

Belgium

Ordinary

99

-

Dieu Services BV

Belgium

Ordinary

99

-

SHU Services BV

Belgium

Ordinary

99

-

CVA Services BV

Belgium

Ordinary

99

-

UV Services BV

Belgium

Ordinary

99

-

Champ du Roi Services BV

Belgium

Ordinary

99

-

 

IVC Acquisition Ltd

Notes to the Financial Statements for the Year Ended 30 September 2020 (continued)

 

22

List of companies (continued)

Hulsterheide Services BV

Belgium

Ordinary

99

-

Aan De Heikant BV

Belgium

Ordinary

99

-

Nieuwe Dijk Services BV

Belgium

Ordinary

99

-

Nutridei SA

Belgium

Ordinary

99

-

AC Services BV

Belgium

Ordinary

99

-

Gouden Poort Services BV

Belgium

Ordinary

99

-

Clos Fleuri Services BV

Belgium

Ordinary

99

-

Assist Services BV

Belgium

Ordinary

99

-

Heide Ooms Services BV

Belgium

Ordinary

99

-

Alpha Services BV

Belgium

Ordinary

99

-

Bosberg Services BV

Belgium

Ordinary

99

-

Animalis Services BV

Belgium

Ordinary

99

-

Evidensia Danmark ApS*

Denmark

Ordinary

-

100

Evidensia Dyrehospital A/S

Denmark

Ordinary

100

100

Evidensia Academy ApS*

Denmark

Ordinary

-

100

Independent Vetcare Finance Limited

England & Wales

Ordinary

100

100

IVC Topco Limited

England & Wales

Ordinary

100

100

Independent Vetcare Limited

England & Wales

Ordinary

100

100

IVC Limited

England & Wales

Ordinary

100

100

IVC Group International Limited

England & Wales

Ordinary

100

100

Petprescriptions Limited

England & Wales

Ordinary

100

100

Orwell Vets Limited

England & Wales

Ordinary

100

100

IVC (TB) Limited

England & Wales

Ordinary

100

100

Lansdown Veterinary Services Limited

England & Wales

Ordinary

100

100

Berry House Limited

England & Wales

Ordinary

100

100

Chase Vets Limited

England & Wales

Ordinary

100

100

Rhodes Veterinary Practice Limited

England & Wales

Ordinary

100

100

Purton Vets Limited

England & Wales

Ordinary

100

100

Oakfield Pet Health Centre Limited

England & Wales

Ordinary

100

100

Chase Vets Eastbourne Limited

England & Wales

Ordinary

100

100

Congleton Veterinary Centre Limited

England & Wales

Ordinary

100

100

Fields Vets Limited

England & Wales

Ordinary

100

100

Cheshire Vets Medical Centre Limited

England & Wales

Ordinary

100

100

Wellpetclinic Limited

England & Wales

Ordinary

100

100

Orchard Vets Limited

England & Wales

Ordinary

100

100

Westwood Veterinary Practice

England & Wales

Ordinary

100

100

1066 Veterinary Centre

England & Wales

Ordinary

100

100

Corinium Veterinary Clinic Limited

England & Wales

Ordinary

100

100

 

IVC Acquisition Ltd

Notes to the Financial Statements for the Year Ended 30 September 2020 (continued)

 

22

List of companies (continued)

Millpark Veterinary Centre Limited

England & Wales

Ordinary

100

100

Well Pets Veterinary Centre Limited

England & Wales

Ordinary

100

100

Kingston Veterinary Group Limited

England & Wales

Ordinary

100

100

The Veterinary Hospital Limited

England & Wales

Ordinary

100

100

Richard Hillman Veterinary Centre Limited

England & Wales

Ordinary

100

100

St Mary’s Veterinary Practice Limited

England & Wales

Ordinary

100

100

Celyn House Limited

England & Wales

Ordinary

100

100

Island Veterinary Service Limited

England & Wales

Ordinary

100

100

Gatehouse Veterinary Centre Limited

England & Wales

Ordinary

100

100

Northdale Veterinary Practice Limited

England & Wales

Ordinary

100

100

Lowesmoor House Vets Limited

England & Wales

Ordinary

100

100

Croft Vets Limited

England & Wales

Ordinary

100

100

Well House Vets Limited

England & Wales

Ordinary

100

100

Clifton Veterinary Practice

England & Wales

Ordinary

100

100

J Dinsdale Limited

England & Wales

Ordinary

100

100

Alexander Veterinary Centre Limited

England & Wales

Ordinary

100

100

Rhyd Broughton Veterinary Group Limited

England & Wales

Ordinary

100

100

Abbey Vets (NE) Limited

England & Wales

Ordinary

100

100

Burch Vets Limited

England & Wales

Ordinary

100

100

A & J Practice Management Limited

England & Wales

Ordinary

100

100

Terrington Vets Limited

England & Wales

Ordinary

100

100

Abbeydale Vets Limited

England & Wales

Ordinary

100

100

Forest Lodge Veterinary Practice Limited

England & Wales

Ordinary

100

100

Zetland Limited

England & Wales

Ordinary

100

100

Thanet One Limited

England & Wales

Ordinary

100

100

The Veterinary Clinic (Bearwood) Limited

England & Wales

Ordinary

100

100

Barton Lodge Veterinary Centre Limited

England & Wales

Ordinary

100

100

Three Rivers Vets Limited

England & Wales

Ordinary

100

100

St Georges Veterinary Group Limited

England & Wales

Ordinary

100

100

The Croft Veterinary Centre (Wolverhampton) Limited

England & Wales

Ordinary

100

100

Acorn Veterinary Practice Limited

England & Wales

Ordinary

100

100

Mintlaw Vets Limited

England & Wales

Ordinary

100

100

Budget Vets Limited

England & Wales

Ordinary

100

100

Williams and Cummings Veterinary Group

England & Wales

Ordinary

100

100

Wellpets Animal Care Limited

England & Wales

Ordinary

100

100

Mill House Vets Limited

England & Wales

Ordinary

100

100

Albert Cottage Veterinary Clinic Limited

England & Wales

Ordinary

100

100

Grove Lodge Veterinary Group Limited

England & Wales

Ordinary

100

100

 

IVC Acquisition Ltd

Notes to the Financial Statements for the Year Ended 30 September 2020 (continued)

 

22

List of companies (continued)

Robson & Prescott Limited

England & Wales

Ordinary

100

100

Abbeymoor Veterinary Centres Limited

England & Wales

Ordinary

100

100

Rosehill Vets Limited

England & Wales

Ordinary

100

100

Blenheim Veterinary Centre Limited

England & Wales

Ordinary

100

100

Beeches Veterinary Centre Limited

England & Wales

Ordinary

100

100

Shipley Vets Limited

England & Wales

Ordinary

100

100

Brownlow Veterinary Group Limited

England & Wales

Ordinary

100

100

Victoria Veterinary Practice Limited

England & Wales

Ordinary

100

100

Parkvets Limited

England & Wales

Ordinary

100

100

My Vet Limited

England & Wales

Ordinary

100

100

Haughley Veterinary Centre Limited

England & Wales

Ordinary

100

100

Moorview Veterinary Practice Limited

England & Wales

Ordinary

100

100

Usk Veterinary Centre Limited

England & Wales

Ordinary

100

100

Cardiff Pet Health Limited

England & Wales

Ordinary

100

100

Summerhill Veterinary Centre Limited

England & Wales

Ordinary

100

100

Hall Place Veterinary Centre Limited

England & Wales

Ordinary

100

100

Easipetcare Limited

England & Wales

Ordinary

100

100

Alpha Veterinary Practice Limited

England & Wales

Ordinary

100

100

Kapsapea Limited

England & Wales

Ordinary

100

100

The Veterinary Clinic Limited

England & Wales

Ordinary

100

100

Wherry Veterinary Practice Limited

England & Wales

Ordinary

100

100

Market Veterinary Centre Limited

England & Wales

Ordinary

100

100

LWAH Limited

England & Wales

Ordinary

100

100

NEVC Limited

England & Wales

Ordinary

100

100

Avon Lodge Veterinary Centre Limited

England & Wales

Ordinary

100

100

Glaven Veterinary Practice Limited

England & Wales

Ordinary

100

100

Taverham Veterinary Practice Holdings Limited

England & Wales

Ordinary

100

100

Taverham Veterinary Practice Limited

England & Wales

Ordinary

100

100

DVG Limited

England & Wales

Ordinary

100

100

The Colourful Consultancy Limited

England & Wales

Ordinary

100

100

Saxon Vets Limited

England & Wales

Ordinary

100

100

Steffan Veterinary Services Limited

England & Wales

Ordinary

100

100

Gilmore Pet Surgery Limited

England & Wales

Ordinary

100

100

A.C. Rawlins Limited

England & Wales

Ordinary

100

100

Bilton Veterinary Centre Limited

England & Wales

Ordinary

100

100

New Street Vets Limited

England & Wales

Ordinary

100

100

AVC 35 Limited

England & Wales

Ordinary

100

100

Castle Vets Pet Heathcare Limited

England & Wales

Ordinary

100

100

 

IVC Acquisition Ltd

Notes to the Financial Statements for the Year Ended 30 September 2020 (continued)

 

22

List of companies (continued)

Dohne and Friends Limited

England & Wales

Ordinary

100

100

Barrow Hill Veterinary Group Limited

England & Wales

Ordinary

100

100

Bourne Practice Limited

England & Wales

Ordinary

100

100

Twickenham Vets Limited

England & Wales

Ordinary

100

100

Ark Veterinary Centre (Colchester) Limited

England & Wales

Ordinary

100

100

Hart Veterinary Limited

England & Wales

Ordinary

100

100

Blackberry Veterinary Clinic Limited

England & Wales

Ordinary

100

100

Hook Veterinary Centre Limited

England & Wales

Ordinary

100

100

Fivelands Veterinary Centre Limited

England & Wales

Ordinary

100

100

H G H (V S) Limited

England & Wales

Ordinary

100

100

Petsco Limited

England & Wales

Ordinary

100

100

Petsco 2 Limited

England & Wales

Ordinary

100

100

Oakmount Veterinary Centre Limited

England & Wales

Ordinary

100

100

The Barn Veterinary Practice Limited

England & Wales

Ordinary

100

100

Williams Vet Care Limited

England & Wales

Ordinary

100

100

Forest Vets Limited

England & Wales

Ordinary

100

100

Gilmore Pet Surgery Limited

England & Wales

Ordinary

100

100

Biscot Mill Veterinary Centre Limited

England & Wales

Ordinary

100

100

Amery Vets Limited

England & Wales

Ordinary

100

100

Towerwood Holdings Limited

England & Wales

Ordinary

100

100

Towerwood Vets Limited

England & Wales

Ordinary

100

100

Mainstone Veterinary Clinic Limited

England & Wales

Ordinary

100

100

Corner House Veterinary Practice Limited

England & Wales

Ordinary

100

100

Pets First Limited

England & Wales

Ordinary

100

100

Crown House Surgery Limited

England & Wales

Ordinary

100

100

The Vets’ Place Limited

England & Wales

Ordinary

100

100

Holmefield Veterinary Clinics Limited

England & Wales

Ordinary

100

100

Aniwell Veterinary Company Limited

England & Wales

Ordinary

100

100

Avon Lodge Veterinary Group Limited

England & Wales

Ordinary

100

100

Lawrence Veterinary Centre Limited

England & Wales

Ordinary

100

100

London Road Veterinary Centre Limited

England & Wales

Ordinary

100

100

Hawthorne Lodge Veterinary Practice Limited

England & Wales

Ordinary

100

100

Mcphersons Veterinary Practice Limited

England & Wales

Ordinary

100

100

Midforest Veterinary Practice Limited

England & Wales

Ordinary

100

100

Carmel Veterinary Centre Limited

England & Wales

Ordinary

100

100

The Shreen Veterinary Practice Limited

England & Wales

Ordinary

100

100

Wilton House Veterinary Clinic Limited

England & Wales

Ordinary

100

100

Woodland Veterinary Centre

England & Wales

Ordinary

100

100

 

IVC Acquisition Ltd

Notes to the Financial Statements for the Year Ended 30 September 2020 (continued)

 

22

List of companies (continued)

Beech House Veterinary Centre

England & Wales

Ordinary

100

100

Advanced Vetcare Limited

England & Wales

Ordinary

100

100

Mearley Vets Limited

England & Wales

Ordinary

100

100

Alder Veterinary Practice (Spalding Limited)

England & Wales

Ordinary

100

100

Chapelfield Veterinary Partnership Limited

England & Wales

Ordinary

100

100

Pro-Vets Group Limited

England & Wales

Ordinary

100

100

Manor Vets Limited

England & Wales

Ordinary

100

100

Foxcotte Veterinary Clinics Limited

England & Wales

Ordinary

100

100

Abivale Veterinary Limited

England & Wales

Ordinary

100

100

Vale Vets Limited

England & Wales

Ordinary

100

100

Vale Animal Limited

England & Wales

Ordinary

100

100

Colebrook Vets Limited

England & Wales

Ordinary

100

100

Letchworth Veterinary Care Limited

England & Wales

Ordinary

100

100

Willow Veterinary Care Limited

England & Wales

Ordinary

100

100

Boness Veterinary Enterprises

England & Wales

Ordinary

100

100

Lydon Veterinary Centre Limited

England & Wales

Ordinary

100

100

Deane Veterinary Centre Limited

England & Wales

Ordinary

100

100

Brown & Bentley Limited

England & Wales

Ordinary

100

100

Walpole & Bingham Limited

England & Wales

Ordinary

100

100

Shorewood Consultants Limited

England & Wales

Ordinary

100

100

Kingsteignton Vets Limited

England & Wales

Ordinary

100

100

West Midlands Vets Limited

England & Wales

Ordinary

100

100

Veterinary Drugs To Go

England & Wales

Ordinary

100

100

Frontfoot Consultancy Suffolk Limited

England & Wales

Ordinary

100

100

Amery Vets Limited

England & Wales

Ordinary

100

100

Wellpets Limited

England & Wales

Ordinary

100

100

Crossroads Veterinary Services Limited

England & Wales

Ordinary

100

100

GP Vets Limited

England & Wales

Ordinary

100

100

Lakeside Veterinary Surgery Limited

England & Wales

Ordinary

100

100

Sampson Park Limited

England & Wales

Ordinary

100

100

Stamford Veterinary Centre Limited

England & Wales

Ordinary

100

100

Norcross Veterinary Limited

England & Wales

Ordinary

100

100

Pool Farm Veterinary Practice Limited

England & Wales

Ordinary

100

100

Alexandra & Hillyfields Vets Limited

England & Wales

Ordinary

100

100

Kieren Peterkin Limited

England & Wales

Ordinary

100

100

FramVet Limited

England & Wales

Ordinary

100

100

Earl Soham Veterinary Centre Limited

England & Wales

Ordinary

100

100

Waverley Veterinary Services Limited

England & Wales

Ordinary

100

100

 

IVC Acquisition Ltd

Notes to the Financial Statements for the Year Ended 30 September 2020 (continued)

 

22

List of companies (continued)

Companion Veterinary Clinic Limited

England & Wales

Ordinary

100

100

Oval Pet Centre Limited

England & Wales

Ordinary

100

100

Mondocane Limited

England & Wales

Ordinary

100

100

Hungerford Vets Limited

England & Wales

Ordinary

100

100

Shield Veterinary Centre Limited

England & Wales

Ordinary

100

100

Bray House Veterinary Services Limited

England & Wales

Ordinary

100

100

Belmont Vets Limited

England & Wales

Ordinary

100

100

Rufford Veterinary Group Limited

England & Wales

Ordinary

100

100

Alcombe Veterinary Practice Limited

England & Wales

Ordinary

100

100

The Laurels Veterinary Centre (Hereford) Limited

England & Wales

Ordinary

100

100

Pet Vets Limited

England & Wales

Ordinary

100

100

Twin Enterprise LimitedSubsidiary: Cambridge Veterinary Group Limited

England & Wales

Ordinary

100

100

Brackley Pet Healthcare Limited

England & Wales

Ordinary

100

100

Westmorland Veterinary Services Limited Inc Westmorland Veterinary Services (Pets) Limited

England & Wales

Ordinary

100

100

Simply Pets - Cheltenham

England & Wales

Ordinary

100

100

North Downs Vets Limited

England & Wales

Ordinary

100

100

Shaw Veterinary Centre Limited

England & Wales

Ordinary

100

100

Crossways Animal Care Limited

England & Wales

Ordinary

100

100

Birch Veterinary Centre Limited

England & Wales

Ordinary

100

100

The Riverside Veterinary Practice Limited

England & Wales

Ordinary

100

100

Strathmore Veterinary Clinic Limited

England & Wales

Ordinary

100

100

Kingsway Veterinary Group

England & Wales

Ordinary

100

100

Fielding & Cumber Limited

England & Wales

Ordinary

100

100

The Neighbourhood Veterinary Centre Limited

England & Wales

Ordinary

100

100

Abbotskerswell Veterinary Centre Limited

England & Wales

Ordinary

100

100

Avenue Veterinary Centre (Malvern) Limited

England & Wales

Ordinary

100

100

Grove Veterinary Centre Limited

England & Wales

Ordinary

100

100

Clent Hills Veterinary Group Limited

England & Wales

Ordinary

100

100

Hawkedon and Homefield Vets Limited

England & Wales

Ordinary

100

100

Wheelhouse Veterinary Centre Limited

England & Wales

Ordinary

100

100

November Limited

England & Wales

Ordinary

100

100

Kernow Veterinary Group Limited

England & Wales

Ordinary

100

100

Lynton House Veterinary Group Limited

England & Wales

Ordinary

100

100

South Lakes Veterinary Centre Limited

England & Wales

Ordinary

100

100

Blake Veterinary Group Limited

England & Wales

Ordinary

100

100

Highcliff Veterinary Practice Limited

England & Wales

Ordinary

100

100

 

IVC Acquisition Ltd

Notes to the Financial Statements for the Year Ended 30 September 2020 (continued)

 

22

List of companies (continued)

The Cheshire Pet Medical Centre (Sandbach) Limited

England & Wales

Ordinary

100

100

Eden Veterinary Centre Limited

England & Wales

Ordinary

100

100

Border Vets (Longtown) Limited

England & Wales

Ordinary

100

100

Ashleigh Veterinary Centre Limited

England & Wales

Ordinary

100

100

Vet On The Hill Limited

England & Wales

Ordinary

100

100

Adamsvet – Pet Care Limited

England & Wales

Ordinary

100

100

Darley House Veterinary Centre Limited

England & Wales

Ordinary

100

100

Straid Veterinary Clinic Limited

England & Wales

Ordinary

100

100

AlphaPet Management Services Limited

England & Wales

Ordinary

100

100

Tother Services Limited (share)

England & Wales

Ordinary

100

100

Mansion Hill Veterinary Practice Limited

England & Wales

Ordinary

100

100

George Hunt & Son Limited

England & Wales

Ordinary

100

100

WHVC Limited

England & Wales

Ordinary

100

100

Cootes Veterinary Clinic Limited

England & Wales

Ordinary

100

100

Scarsdale Vets (Derby) Limited ("Pride Referrals")

England & Wales

Ordinary

100

100

Cogges Veterinary Practice Limited

England & Wales

Ordinary

100

100

Ark House Vets Limited

England & Wales

Ordinary

100

100

Highfield Veterinary Centre Limited

England & Wales

Ordinary

100

100

The Animal House Limited

England & Wales

Ordinary

100

100

Fenwold Veterinary Practice Limited

England & Wales

Ordinary

100

100

Paxton Veterinary Clinics Limited

England & Wales

Ordinary

100

100

Petcare Veterinary Practice Limited

England & Wales

Ordinary

100

100

Leonard Brothers Veterinary Centre Limited

England & Wales

Ordinary

100

-

Horsehead Nebula Limited

England & Wales

Ordinary

100

-

South Lincs Vet Group Limited

England & Wales

Ordinary

100

-

Tother Services Limited

England & Wales

Ordinary

100

-

Greg Toth Limited

England & Wales

Ordinary

100

-

Animates Veterinary Clinic Limited

England & Wales

Ordinary

100

-

Moy Vets Limited

England & Wales

Ordinary

100

-

Azure Blue Services Limited

England & Wales

Ordinary

100

-

Vetspeed Limited

England & Wales

Ordinary

100

-

Paws Colchester Veterinary Centre

England & Wales

Ordinary

100

-

Park Issa Vets Limited

England & Wales

Ordinary

100

-

Tern Vets Limited

England & Wales

Ordinary

100

-

Eden Veterinary Centre Limited

England & Wales

Ordinary

100

-

Marshlands Animal Care Limited

England & Wales

Ordinary

100

-

Bowden & Charlesworth Limited

England & Wales

Ordinary

100

-

Axe Valley Veterinary Practice Limited

England & Wales

Ordinary

100

-

 

IVC Acquisition Ltd

Notes to the Financial Statements for the Year Ended 30 September 2020 (continued)

 

22

List of companies (continued)

Green Lane Vets Limited

England & Wales

Ordinary

100

-

The Vet Centre Limited

England & Wales

Ordinary

100

-

Carterton Veterinary Surgery Limited

England & Wales

Ordinary

100

-

Veterinary Healthcare Limited

England & Wales

Ordinary

100

-

Bell & Partners Limited

England & Wales

Ordinary

100

-

Fyrnwy Equine Group Limited

England & Wales

Ordinary

100

-

Manor Farm Vets Limited

England & Wales

Ordinary

100

-

Priory Vets Cardigan Limited

England & Wales

Ordinary

100

-

Ark Veterinary Practise Limited

England & Wales

Ordinary

100

-

New Priory Vets Brighton Limited

England & Wales

Ordinary

100

-

Cedar Grove Veterinary Clinic Limited

England & Wales

Ordinary

100

-

Orby Vets Limited

England & Wales

Ordinary

100

-

The Mobile Vet Limited

England & Wales

Ordinary

100

-

Animal House Vets Limited

England & Wales

Ordinary

100

-

Highcroft (Hailsham) Limited

England & Wales

Ordinary

100

-

Heartland Veterinary Services Limited

England & Wales

Ordinary

100

-

IVSR Limited

England & Wales

Ordinary

100

-

Wellpet Veterinary Practise Limited

England & Wales

Ordinary

100

-

Catley Cross Veterinary Clinic Limited

England & Wales

Ordinary

100

-

Bowden South Normanton Limited

England & Wales

Ordinary

100

-

Ashbank Vet Centre Limited

England & Wales

Ordinary

100

-

Asbank Holdings Limited

England & Wales

Ordinary

100

-

UniVet Holding Oy *

Finland

Ordinary

100

100

Verna OY

Finland

Ordinary

100

100

Evidensia Eläinlääkäripalvelut Oy

Finland

Ordinary

100

100

Toijalan Eläinlääkäriasema Oy

Finland

Ordinary

100

100

Univet Kalanti OY

Finland

Ordinary

51

51

Animagi Hevosklinikat Oy

Finland

Ordinary

100

100

E-Laaketukku Oy

Finland

Ordinary

100

-

Evidensia France SAS

France

Ordinary

100

100

Oncovet SAS

France

Ordinary

49

49

Vetotech SAS

France

Ordinary

49

99

Wivetix Services GIE

France

Ordinary

100

100

Société de vétérinaires des docteurs Garinot, Frenay et Le Faucheur

France

Ordinary

49

-

Opal’Vet SAS

France

Ordinary

49

-

BCDH

France

Ordinary

49

-

CHV Fregis

France

Ordinary

49

-

 

IVC Acquisition Ltd

Notes to the Financial Statements for the Year Ended 30 September 2020 (continued)

 

22

List of companies (continued)

SCP Vétérinaires Warmoes Croisier

France

Ordinary

49

-

SCP Campaignie Weil

France

Ordinary

49

49

SELARL Clinique Veterinaire des Genets

France

Ordinary

49

-

SELARL des Barbes d’Or

France

Ordinary

49

-

Evolia

France

Ordinary

49

-

Societe Veterinaire Des Cordeliers

France

Ordinary

49

-

Vétérinaires Associés CVA

France

Ordinary

49

-

Clinique Vétérinaire du Pont Paul Bert

France

Ordinary

49

-

Clinique Vétérinaire du Cèdre

France

Ordinary

49

-

SELARL Vet Alienor

France

Ordinary

49

-

Societe Vetoservice

France

Ordinary

49

-

SELARL CastelVet

France

Ordinary

49

-

SELARL Veterinaire Chapelaine

France

Ordinary

49

-

Clinique Vétérinaire des Lys

France

Ordinary

49

-

Languedovet

France

Ordinary

49

-

SELARL des Docteurs Veterinaires des Bastides

France

Ordinary

49

-

SELARL La Bastide des Alpilles

France

Ordinary

49

-

SELARL AZIA-BARRAUD-BROCHOT-CASSAGNES-DEMIAUX

France

Ordinary

49

-

SELAR CVDEH

France

Ordinary

49

-

TKS Tierärztliche Klinik Stommeln Gmbh

Germany

Ordinary

100

100

Evidensia Deutschland GmbH *

Germany

Ordinary

100

100

Evidensia Tierärztliche Klinik Betzdorf GmbH

Germany

Ordinary

100

100

Kleintiergesundheits zentrum Ravensburg Evidensia GmbH

Germany

Ordinary

100

100

Tierarztpraxis Dr.Winkler GmbH,

Germany

Ordinary

100

100

Evidensia Vet Zentrum Berchtesgadener Land GmbH

Germany

Ordinary

100

100

Evidensia Vet-Zentrum Rosenheim GmbH

Germany

Ordinary

100

100

Evidensia Tierärztliche Klinik für Kleintiere Norderstedt GmbH

Germany

Ordinary

100

100

Kleintierspezialisten Dres Schmerbach & Höpfner GmbH

Germany

Ordinary

100

100

Tierklinik am Nordring Evidensia Nürnberg GmbH

Germany

Ordinary

100

100

Evidensia Tierkliniken und -praxen Nordrhein GmbH

Germany

Ordinary

100

100

Veteria Fachtierarzt-Zentrum & Tagesklinik GmbH

Germany

Ordinary

100

100

Kleintierpraxis Dr. Swenshon GmbH

Germany

Ordinary

100

100

Tierärztliches Augenzentrum München GmbH

Germany

Ordinary

100

100

Tierarzlliche Klinik Reichenberg Evidensia GmbH

Germany

Ordinary

100

100

Tierarztpraxis Dr Haas GmbH

Germany

Ordinary

100

100

 

IVC Acquisition Ltd

Notes to the Financial Statements for the Year Ended 30 September 2020 (continued)

 

22

List of companies (continued)

Tierarztliche Gemeinschafispraxis Seligenstadt GmbH

Germany

Ordinary

100

100

Kleintierzentrum AM Kurpark Numbrecht GmbH

Germany

Ordinary

100

100

Tierarztpraxis Strassenheim GmbH

Germany

Ordinary

100

100

Tierarztpraxis Eiserfeld Evidensia GmbH

Germany

Ordinary

100

-

Kleintierpraxis Rendsburg Evidensia GmbH

Germany

Ordinary

100

-

Tiergesundheit Volkach Evidensia GmbH

Germany

Ordinary

100

-

Tierklinik Stadtsteinach Evidensia GmbH

Germany

Ordinary

100

-

Kleintierzentrum Heidenheim GmbH

Germany

Ordinary

100

-

Kleintierpraxis Kaiserslautern Evidensia GmbH

Germany

Ordinary

100

-

Kleintierzentrum Knoop GmbH

Germany

Ordinary

100

-

Kleintierpraxis Harrislee Evidensia GmbH

Germany

Ordinary

100

-

Tierarztpraxis Dr Schilling GmbH

Germany

Ordinary

100

100

Tierärzte Gelnhausen IVC Evidensia GmbH

Germany

Ordinary

100

-

Evidensia Tiergesundheitszentrum 025 GmbH

Germany

Ordinary

100

-

Evidensia Tiergesundheitszentrum 026 GmbH

Germany

Ordinary

100

-

Evidensia Tiergesundheitszentrum 027 GmbH

Germany

Ordinary

100

-

Evidensia Tiergesundheitszentrum 028 GmbH

Germany

Ordinary

100

-

Tierärzte IVC Evidensia GmbH

Germany

Ordinary

100

-

Kleintierpraxis Maintal Evidensia GmbH

Germany

Ordinary

100

-

Independent Vetcare Ireland Limited

Ireland

Ordinary

100

100

Anicare Veterinary Facilities Limited

Ireland

Ordinary

100

100

Athlone Veterinary Centre Limited

Ireland

Ordinary

100

-

Milltown Veterinary Services Limited

Ireland

Ordinary

100

-

Beaufield Veterinary Centre

Ireland

Ordinary

100

-

Vetstore Limited

Ireland

Ordinary

100

-

Drogheda Petmedical Limited

Ireland

Ordinary

100

-

Milan Veterinary Limited

Isle of Man

Ordinary

100

100

Arg Beiyn Limited

Isle of Man

Ordinary

100

100

Evidensia Nederland B.V. *

Netherlands

Ordinary

100

100

Evidensia B B.V.*

Netherlands

Ordinary

-

100

Evidensia 017 B.V.*

Netherlands

Ordinary

-

100

Evidensia 016 B.V.*

Netherlands

Ordinary

-

100

Evidensia A B.V.*

Netherlands

Ordinary

-

100

Evidensia 040 B.V.*

Netherlands

Ordinary

-

100

Evidensia 027 B.V*

Netherlands

Ordinary

-

100

Dierenkliniek de Postwagen B.V*

Netherlands

Ordinary

-

100

Evidensia 037 B.V.

Netherlands

Ordinary

100

100

Evidensia 024 B.V.

Netherlands

Ordinary

100

100

 

IVC Acquisition Ltd

Notes to the Financial Statements for the Year Ended 30 September 2020 (continued)

 

22

List of companies (continued)

Evidensia 028 B.V.*

Netherlands

Ordinary

-

100

Evidensia 032 B.V.*

Netherlands

Ordinary

-

100

Evidensia 039 B.V*

Netherlands

Ordinary

-

100

Evidensia 040 B.V*

Netherlands

Ordinary

-

100

Evidensia 041 B.V

Netherlands

Ordinary

-

100

Evidensia 042 B.V

Netherlands

Ordinary

-

100

Evidensia 043 B.V

Netherlands

Ordinary

-

100

Evidensia 044 B.V

Netherlands

Ordinary

-

100

Evidensia 045 B.V

Netherlands

Ordinary

-

100

Evidensia 046 B.V

Netherlands

Ordinary

-

100

Evidensia 047 B.V

Netherlands

Ordinary

-

100

Evidensia 050 B.V

Netherlands

Ordinary

-

100

Tandheelkundig Dierenarts Knaake B.V.

Netherlands

Ordinary

100

100

Dierenuitvaartzorg Nederland B.V.

Netherlands

Ordinary

100

-

Huisdieren- en paardencrematorium Rotterdam B.V.

Netherlands

Ordinary

100

100

Dierenartsenpraktjik Landsmeer B.V.*

Netherlands

Ordinary

-

100

Dierenartsenpraktijk Zuidwolde B.V.*

Netherlands

Ordinary

-

100

Dierenkliniek Duurstede B.V.*

Netherlands

Ordinary

-

100

Dierenkliniek Stad & Land B.V.*

Netherlands

Ordinary

-

100

Stad & Land Dierenklinieken Alkmaar B.V.*

Netherlands

Ordinary

-

100

Stad & Land Dierenklinieken Wormerveer B.V.*

Netherlands

Ordinary

-

100

Stad & Land Dierenklinieken Hoorn B.V.*

Netherlands

Ordinary

-

100

Stad & Land Dierenklinieken Amstelveen B.V.*

Netherlands

Ordinary

-

100

Het Arendsnest B.V. (holdco)*, Subsidiaries: SHCN Dierenuitvaart B.V.; Dierbaar Dierenuitvaart B.V.;

Netherlands

Ordinary

-

100

Dierenzorg B.V., Dierencrematorium Parkstad B.V. and Dierenkrematorium Beek B.V.*

Netherlands

Ordinary

-

100

SKDU en DGC B.V.*

Netherlands

Ordinary

-

100

Lingsesdijk B.V.*

Netherlands

Ordinary

-

100

De Graafschap Dierenartsen B.V.*

Netherlands

Ordinary

-

100

Dierenartsenpraktijk Zelhem B.V.*

Netherlands

Ordinary

-

100

Pet Health Care BV*

Netherlands

Ordinary

-

100

Dierenkliniek Bloombird BV*

Netherlands

Ordinary

-

100

Dierenkliniek Zuidoostbeemister BV*

Netherlands

Ordinary

-

100

J de Jong Dierenartsen BV

Netherlands

Ordinary

100

100

Evidensia Dierenklinieken B.V.

Netherlands

Ordinary

100

100

Evidensia NL Dierenklinieken B.V.

Netherlands

Ordinary

100

100

Evidensia P B.V.

Netherlands

Ordinary

100

-

 

IVC Acquisition Ltd

Notes to the Financial Statements for the Year Ended 30 September 2020 (continued)

 

22

List of companies (continued)

Dierenkliniek Zuiderkaag B.V.

Netherlands

Ordinary

100

-

Dierenkliniek Venray B.V.

Netherlands

Ordinary

100

-

Plus Dierenkliniek Saendelft B.V.

Netherlands

Ordinary

100

-

Plus Dierenkliniek De Saen B.V.

Netherlands

Ordinary

100

-

Dierenkliniek Keistad B.V.

Netherlands

Ordinary

100

-

Dierenartsenpraktijk Moerstraten B.V.

Netherlands

Ordinary

100

-

Glas Diergeneeskunde B.V.

Netherlands

Ordinary

100

-

Dierenartsenpraktijk Berghem B.V.

Netherlands

Ordinary

100

-

ABC voor Dieren B.V.

Netherlands

Ordinary

100

-

DKL Putten B.V.

Netherlands

Ordinary

100

-

Dierenkliniek Het Zicht – De Duinen B.V.

Netherlands

Ordinary

100

-

Dierenkliniek Middeldiep B.V.

Netherlands

Ordinary

100

-

Diergeneeskundig Centrum Alblasserwaard B.V.

Netherlands

Ordinary

100

-

Basic Vets Dordrecht B.V.

Netherlands

Ordinary

100

-

Basic Vets Groep Nederland B.V.

Netherlands

Ordinary

100

-

Glenshane Veterinary Clinics Limited

Northern Ireland

Ordinary

100

100

Rathgael Veterinary Clinic Limited

Northern Ireland

Ordinary

100

100

Cedarmount Veterinary Clinic Limited

Northern Ireland

Ordinary

100

100

Earlswood Veterinary Referrals

Northern Ireland

Ordinary

100

100

Fenaghy Veterinary Clinic (NI) Limited

Northern Ireland

Ordinary

100

100

Roe Valley Veterinary Clinic Limited

Northern Ireland

Ordinary

100

100

CVG (D.C.) Limited

Northern Ireland

Ordinary

100

100

Glenburn Veterinary Centre Limited

Northern Ireland

Ordinary

100

100

Drumahoe Veterinary Clinic Limited

Northern Ireland

Ordinary

100

100

Clare Veterinary Practise Limited

Northern Ireland

Ordinary

100

100

Knockanboy Veterinary Clinic Limited

Northern Ireland

Ordinary

100

100

Evidensia Dyrehelse AS *

Norway

Ordinary

100

100

Smådyrkrematoriet AS

Norway

Ordinary

100

100

Kristiansand Dyreklinikk AS*

Norway

Ordinary

-

100

Evidensia Smådyr AS

Norway

Ordinary

100

100

Vestfold Dyrehospital (iVet) AS*

Norway

Ordinary

-

100

Sentrum Dyreklinik AS*

Norway

Ordinary

-

100

Moseng Dyreklinik AS*

Norway

Ordinary

-

100

Crown Veterinary Services Limited

Scotland

Ordinary

100

100

The Cambushinnie Service Company Limited

Scotland

Ordinary

100

100

K & M Donald Limited

Scotland

Ordinary

100

100

Shore Veterinary Centre Limited

Scotland

Ordinary

100

100

Boyce & Houston Limited

Scotland

Ordinary

100

100

 

IVC Acquisition Ltd

Notes to the Financial Statements for the Year Ended 30 September 2020 (continued)

 

22

List of companies (continued)

Vermuyden Veterinary Practice Limited

Scotland

Ordinary

100

100

Kilbarchan Veterinary Practice Limited

Scotland

Ordinary

100

100

Avondale Veterinary Services Limited

Scotland

Ordinary

100

100

Aberdeen Veterinary Referrals

Scotland

Ordinary

100

100

PVG (Fife) Limited

Scotland

Ordinary

100

100

Forth Valley Vets Limited

Scotland

Ordinary

100

100

DentalVets Limited

Scotland

Ordinary

100

100

Taylor Veterinary Practice Limited

Scotland

Ordinary

100

100

Ardene House Vet Practice Limited

Scotland

Ordinary

100

100

Crieff Vets Limited

Scotland

Ordinary

100

100

The Lamond Veterinary Clinic Limited

Scotland

Ordinary

100

100

Easter Ross Vets Limited

Scotland

Ordinary

100

100

Robson Vets Limited

Scotland

Ordinary

100

100

Macmerry Pet and Horse Centre Limited

Scotland

Ordinary

100

100

ICR Veterinary Group Limited

Scotland

Ordinary

100

100

Shedden Vets Limited

Scotland

Ordinary

100

100

Fife Referrals Limited

Scotland

Ordinary

100

100

Martin Veterinary Centre Limited

Scotland

Ordinary

100

100

Jackson Vets Limited

Scotland

Ordinary

100

100

MBM Vets Limited

Scotland

Ordinary

100

100

Abervet 2015 Limited

Scotland

Ordinary

100

100

The Dermatology Referral Service Limited

Scotland

Ordinary

100

100

Vets Now Limited

Scotland

Ordinary

100

100

VN Holdings Limited

Scotland

Ordinary

100

100

Vets Now Emergency Limited

Scotland

Ordinary

100

100

Inglis Veterinary Centres Limited

Scotland

Ordinary

100

100

Gordon Vets Limited

Scotland

Ordinary

100

-

Nithsdale Vets Limited

Scotland

Ordinary

100

-

Glenbrae Veterinary Clinic Limited

Scotland

Ordinary

100

-

Evidensia Holding AB *

Sweden

Ordinary

100

100

Evidensia Acquisition AB *

Sweden

Ordinary

100

100

Evidensia Djursjukvård Holding AB *

Sweden

Ordinary

100

100

Evidensia Djursjukvård AB *

Sweden

Ordinary

100

100

K64 Stockholm AB

Sweden

Ordinary

100

100

Evidensia Häst AB *

Sweden

Ordinary

100

100

Evidensia Smådjur AB *

Sweden

Ordinary

100

100

Cremit AB

Sweden

Ordinary

100

100

Ulvsby Smadjursklinik AB

Sweden

Ordinary

100

100

 

IVC Acquisition Ltd

Notes to the Financial Statements for the Year Ended 30 September 2020 (continued)

 

22

List of companies (continued)

Lekebergs Smådjurskremering AB

Sweden

Ordinary

100

-

Kleintierpraxis ACR AG

Switzerland

Ordinary

100

100

Bessy´s Kleintierklinik AG

Switzerland

Ordinary

100

100

ENNETSeeKLINIK für Kleintiere AG

Switzerland

Ordinary

100

100

Kleintierpraxis Schwäntenmos AG

Switzerland

Ordinary

100

100

Clinique VETérinaire Dr D. Stornetta Dr J.-B. Deillon

Switzerland

Ordinary

100

-

All of the above are indirectly owned subsidiaries except the ones listed in note 12. The principal activity of all companies is the provision of veterinary services other than those indicated with * who's principal activity is that of an intermediate holding company.